Published • loading... • Updated
Jakob Mainz: Driving Responsible AI Innovation in Pharma
Summary by Hyperight
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Jakob Mainz: Driving Responsible AI Innovation in Pharma
This week we are spotlighting Jakob Mainz, Director of AI Governance in R&D at Novo Nordisk, where he leads a specialized team of experts responsible for defining the processes, controls, and tooling required to implement AI safely in drug discovery and development. His team works to enable the use of emerging data types like imaging and “omics” data, while actively driving the company’s R&D AI Council and advising executive leaders on how to de…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
